Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

NeuroLogica Corporation Receives Chinese FDA & CQC Approval To Provide Its CereTom Portable CT Scanner Throughout China
NeuroLogica Corporation, a provider of pioneering portable imaging equipment in CT and SPECT, announced its expansion into the Chinese medical device market with the approval of the company"s life saving CereTom portable CT Scanner by the Chinese State Food and Drug Administration (FDA). The company also announced that it will establish a business liaison office in Beijing.
generic viagra online
News Examines Lawmakers' Contributions In Health Reform Debate
Over the last 27 sessions of Congress, there has always been a Dingell universal health care bill, introduced first by Rep. John D. Dingell"s father during World War II, and then by his son, The Washington Times reports.
News of the day
What Rorschach Tests Really Tell Us
One of the most well-known psychological tools is the Rorschach Inkblot Test. A viewer looks at ten inkblots, one at a time, and describes what they see. The rationale behind this test is the idea that certain aspects of the subject"s personality will be exposed as they are interpreting the images, allowing for the possible diagnosis of various psychological disorders. However, does the inkblot really reveal all? Psychological Science in the Public Interest, a journal of the Association for Psychological Science, published an exhaustive review of all data on the Rorschach (and other similar "projective" tests) in 2000. Such meta-analyses are major undertakings, so although this report is a few years old, it remains the most definitive word on the Rorschach. According to authors Scott O. Lilienfeld of Emory University, James M. Wood of University of Texas at El Paso, and Howard N. Garb of the University of Pittsburgh, despite its popularity, the Rorschach may not be the best diagnostic tool and practitioners need to be cautious in how they use this technique and interpret their results.
Public Health

First Robotic Lung Surgery In Tampa Bay Performed At Moffitt Cancer Center

Ray Berkelbach is taking long walks three times a day just a couple weeks after having lung surgery. The 68-year-old retiree from Punta Gorda underwent robotic surgery at Moffitt Cancer Center to remove a cancerous part of his lung. His was the first lung procedure in the Tampa Bay area that used the robot-assisted da Vinci surgical system. "This took nothing out of me. I"ve had no pain," said Berkelbach. "People look at me and can"t believe I just had a lung operation." Lung surgeries are very complex operations because of the large vessels leading to and from the lungs and heart. Unlike the traditional open-chest method, the da Vinci system allows surgeons to perform minimally invasive procedures by guiding robotic arms as they make tiny incisions. The new technique promises minimal trauma to the patient and better surgical results. "The da Vinci robotic technology is incredible. It allows me greater operative dexterity and manipulation," said Dr. Eric Sommers, the thoracic surgeon at Moffitt who did Berkelbach"s procedure. "You can do things with the robot that you couldn"t dream of doing with human hands, all through tiny ports." Only early stage lung cancer patients are candidates for the robotic procedure. The benefits include shorter hospital stays and decreased pain and discomfort. Berkelbach was the first patient at Moffitt to undergo the da Vinci lung surgery. "The incisions from two weeks ago have already healed," said Berkelbach. "It"s hard to believe they took half a lung out. I"m going farther each day on my walks and I"d like to get back to golfing soon." Moffitt is already using the same robotic technology for prostate , kidney, bladder, testicular and uterine cancers. Moffitt Cancer Center & Research Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009